by Stroke Diagnostic and Therapeutic Market size is expected to grow Usd 65.6 bn by 2030 at a CAGR of 8% over the forecast period 2021 – 2030.
A new study on the global Stroke Diagnostic and Therapeutic market has been published by Precedence Research. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global Stroke Diagnostic and Therapeutic market. The study offers valuable information about the global Stroke Diagnostic and Therapeutic market to illustrate how the market would grow during the forecast period 2021-2030. The report provides the value and volume of the global Stroke Diagnostic and Therapeutic market for the period 2021–2030, considering 2019 as the base year and 2030 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.
Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global Stroke Diagnostic and Therapeutic market during the forecast period.
Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1212
An extensive analysis on business strategies of leading market players is also featured in study on the global Stroke Diagnostic and Therapeutic market. This can help readers understand principal factors to foresee growth in the global Stroke Diagnostic and Therapeutic market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.
The report also delves into the competition landscape of the global Stroke Diagnostic and Therapeutic market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.
Key Players
- Neural Analytics
- Cordis Corporation
- Cerebrotech Medical Systems, Inc.
- Koninklijke Philips N.V.
- Medtronic plc.
- Boston Scientific Corporation
- GE Healthcare
- Medfield Diagnostics
- Samsung Neurologica
- NIRX
- Gowerlabs
- Siemens AG
- Genentech Inc.
- Merck & Co., Inc.
- Hyperfine MRI
- Stryker Corporation
- Abbott Laboratories
Key Questions Answered in Stroke Diagnostic and Therapeutic Market Study
– What are the key factors influencing the Stroke Diagnostic and Therapeutic market in each region?
– What will be the CAGR of the global Stroke Diagnostic and Therapeutic market between 2017 and 2030?
– What is the future scope and changing trends in technologies in the global Stroke Diagnostic and Therapeutic market?
– Which factors will impede the growth of the global Stroke Diagnostic and Therapeutic market during the forecast period?
– Which are the leading companies in the global Stroke Diagnostic and Therapeutic market?
– Which region is set to expand at the fastest CAGR during the forecast period?
– What is the volume (Units) of different Stroke Diagnostic and Therapeutic across all regions during the forecast period?
– Which segment will have the highest revenue globally in 2030 and which segment will expand at the fastest CAGR during the forecast period?
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1212
Research Methodology
A unique research methodology has been utilized by precedence research to conduct a comprehensive research on the growth of the global Stroke Diagnostic and Therapeutic market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global Stroke Diagnostic and Therapeutic market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from Stroke Diagnostic and Therapeutic industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making precedence research estimates on the future prospects of the global market more reliable and accurate.
Segmentation
By Type
- Diagnostics
-
-
- Magnetic Resonance Imaging (MRI)
- Computed Tomography Scan (CT scan)
- Electrocardiography
- Carotid Ultrasound
- Cerebral Angiography
- Others
-
- Therapeutics
-
-
- Tissue Plasminogen Activator
- Antiplatelet
- Antihypertensive
- Anticoagulant
-
By Application
- Haemorrhagic Stroke
- Ischemic Stroke
By Geography
- North America
-
-
- U.S.
- Canada
-
- Europe
-
-
- Germany
- France
- United Kingdom
- Rest of Europe
-
- Asia Pacific
-
-
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
-
- Latin America
-
-
- Brazil
- Rest of Latin America
-
- Middle East & Africa (MEA)
-
-
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
-
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Stroke Diagnostic And Therapeutic Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Stroke Diagnostic And Therapeutic Market
5.1. Covid-19: stroke diagnostic and therapeutic Industry Impact
5.2. stroke diagnostic and therapeutic Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and stroke diagnostic and therapeutic Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for stroke diagnostic and Therapeutic Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Stroke Diagnostic And Therapeutic Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1.1. Increasing number of patients at risk of developing stroke
6.1.1.1.2. Increasing patient awareness
6.1.1.1.3. Increased health care expenditure
6.1.2. Market Restraints
6.1.2.1. High cost of treatment and unfavorable reimbursement scenario
6.1.3. Market Opportunities
6.1.3.1. Growing ongoing research & development in the healthcare sector technologies and emerging markets
Chapter 7. Global Stroke Diagnostic And Therapeutic Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. stroke diagnostic and Therapeutic Market Revenue by Market Players (2017 – 2020)
7.1.1.2. stroke diagnostic and Therapeutic Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Stroke Diagnostic And Therapeutic Market, By Type
8.1. stroke diagnostic and Therapeutic Market, by Type, 2017-2030
8.1.1. Diagnostic
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Therapeutics
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Stroke Diagnostic And Therapeutic Market, By Application
9.1. stroke diagnostic and therapeutic Market, by Application, 2017-2030
9.1.1. Haemorrhagic Stroke
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ischemic Stroke
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Stroke Diagnostic And Therapeutic Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Type (2017-2030)
10.1.2. Market Revenue Forecast by Application(2017-2030)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2017-2030)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2017-2030)
10.2. Europe
10.2.1. Market Revenue Forecast by Type (2017-2030)
10.2.2. Market Revenue Forecast by Application (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2017-2030)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2017-2030)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Type (2017-2030)
10.3.2. Market Revenue Forecast by Application (2017-2030)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2017-2030)
10.4. LATAM
10.4.1. Market Revenue Forecast by Type (2017-2030)
10.4.2. Market Revenue Forecast by Application (2017-2030)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2017-2030)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2017-2030)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Type (2017-2030)
10.5.2. Market Revenue Forecast by Application (2017-2030)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2017-2030)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2017-2030)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2017-2030)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2017-2030)
Chapter 11. Company Profiles
11.1. Boston Scientific Corporation
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2017-2020)
11.1.4. Recent Developments and Strategies
11.2. Medtronic plc
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2017-2020)
11.2.4. Recent Developments and Strategies
11.3. Cerebrotech Medical Systems, Inc.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2017-2020)
11.3.4. Recent Developments and Strategies
11.4. Cordis Corporation
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2017-2020)
11.4.4. Recent Developments and Strategies
11.5. Neural Analytics
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2017-2020)
11.5.4. Recent Developments and Strategies
11.6. Koninklijke Philips N.V.
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2017-2020)
11.6.4. Recent Developments and Strategies
11.7. Medfield Diagnostics
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2017-2020)
11.7.4. Recent Developments and Strategies
11.8. GE Healthcare
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2017-2020)
11.8.4. Recent Developments and Strategies
11.9. Samsung Neurologica
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2017-2020)
11.9.4. Recent Developments and Strategies
11.10. Siemens AG
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2017-2020)
11.10.4. Recent Developments and Strategies
11.11. NIRX
11.11.1. Company Overview, Business Information, Regional Presence
11.11.2. Product Portfolio Analysis
11.11.2.1. Product Details, Specification, Application
11.11.3. Revenue, Price, and Gross Margin (2017-2020)
11.11.4. Recent Developments and Strategies
11.12. Gowerlabs
11.12.1. Company Overview, Business Information, Regional Presence
11.12.2. Product Portfolio Analysis
11.12.2.1. Product Details, Specification, Application
11.12.3. Revenue, Price, and Gross Margin (2017-2020)
11.12.4. Recent Developments and Strategies
11.13. Stryker Corporation
11.13.1. Company Overview, Business Information, Regional Presence
11.13.2. Product Portfolio Analysis
11.13.2.1. Product Details, Specification, Application
11.13.3. Revenue, Price, and Gross Margin (2017-2020)
11.13.4. Recent Developments and Strategies
11.14. Genentech Inc.
11.14.1. Company Overview, Business Information, Regional Presence
11.14.2. Product Portfolio Analysis
11.14.2.1. Product Details, Specification, Application
11.14.3. Revenue, Price, and Gross Margin (2017-2020)
11.14.4. Recent Developments and Strategies
11.15. Merck & Co., Inc.
11.15.1. Company Overview, Business Information, Regional Presence
11.15.2. Product Portfolio Analysis
11.15.2.1. Product Details, Specification, Application
11.15.3. Revenue, Price, and Gross Margin (2017-2020)
11.15.4. Recent Developments and Strategies
11.16. Hyperfine MRI
11.16.1. Company Overview, Business Information, Regional Presence
11.16.2. Product Portfolio Analysis
11.16.2.1. Product Details, Specification, Application
11.16.3. Revenue, Price, and Gross Margin (2017-2020)
11.16.4. Recent Developments and Strategies
11.17. Abbott Laboratories
11.17.1. Company Overview, Business Information, Regional Presence
11.17.2. Product Portfolio Analysis
11.17.2.1. Product Details, Specification, Application
11.17.3. Revenue, Price, and Gross Margin (2017-2020)
11.17.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Get Full Access of this Research Report, Click here@ https://www.precedenceresearch.com/checkout/1212
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
